| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
HIV Infections | 33 | 1993 | 136 |
Why?
|
Antiretroviral Therapy, Highly Active | 14 | 2001 | 27 |
Why?
|
Pregnancy Complications, Infectious | 8 | 2005 | 35 |
Why?
|
Anti-HIV Agents | 11 | 2000 | 44 |
Why?
|
HIV-1 | 15 | 1993 | 93 |
Why?
|
AIDS-Related Opportunistic Infections | 11 | 1993 | 41 |
Why?
|
Acquired Immunodeficiency Syndrome | 12 | 1988 | 85 |
Why?
|
Substance-Related Disorders | 2 | 2008 | 96 |
Why?
|
HIV Protease Inhibitors | 3 | 2006 | 25 |
Why?
|
Anti-Retroviral Agents | 2 | 2008 | 13 |
Why?
|
Women's Health | 2 | 2003 | 40 |
Why?
|
Rural Health | 4 | 1994 | 19 |
Why?
|
Medication Adherence | 1 | 2011 | 19 |
Why?
|
Norgestrel | 1 | 2010 | 1 |
Why?
|
Ethinyl Estradiol | 1 | 2010 | 6 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2010 | 4 |
Why?
|
Ritonavir | 1 | 2010 | 10 |
Why?
|
Prenatal Care | 2 | 2008 | 35 |
Why?
|
Contraceptive Agents, Female | 4 | 2005 | 4 |
Why?
|
Pyrimidinones | 1 | 2010 | 14 |
Why?
|
Ovulation Inhibition | 2 | 2006 | 1 |
Why?
|
Medroxyprogesterone Acetate | 2 | 2006 | 5 |
Why?
|
RNA, Viral | 11 | 2000 | 91 |
Why?
|
Estrogens | 1 | 2010 | 45 |
Why?
|
Adult | 40 | 1988 | 1317 |
Why?
|
CD4 Lymphocyte Count | 10 | 2000 | 50 |
Why?
|
United States | 20 | 1993 | 604 |
Why?
|
Female | 45 | 1988 | 1643 |
Why?
|
Pneumonia, Pneumocystis | 7 | 1994 | 28 |
Why?
|
Patient Compliance | 3 | 2008 | 113 |
Why?
|
Street Drugs | 1 | 2008 | 16 |
Why?
|
Vitamins | 1 | 2008 | 30 |
Why?
|
Mycobacterium avium-intracellulare Infection | 3 | 2000 | 7 |
Why?
|
Humans | 53 | 1988 | 1856 |
Why?
|
HIV Seroprevalence | 1 | 2003 | 3 |
Why?
|
Mycobacterium avium Complex | 2 | 2000 | 5 |
Why?
|
Viral Load | 8 | 2000 | 53 |
Why?
|
Clinical Trials as Topic | 3 | 2005 | 251 |
Why?
|
Middle Aged | 21 | 1994 | 1161 |
Why?
|
Health Status | 2 | 1993 | 127 |
Why?
|
Questionnaires | 7 | 1993 | 360 |
Why?
|
Male | 31 | 1988 | 1553 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 22 |
Why?
|
Guideline Adherence | 1 | 2002 | 64 |
Why?
|
Health Care Surveys | 2 | 1997 | 91 |
Why?
|
Pregnancy | 9 | 2005 | 455 |
Why?
|
Drug Interactions | 3 | 2006 | 111 |
Why?
|
Risk Factors | 10 | 1993 | 555 |
Why?
|
Health Services Accessibility | 3 | 1993 | 72 |
Why?
|
Adolescent | 10 | 1993 | 891 |
Why?
|
Rural Health Services | 2 | 1997 | 10 |
Why?
|
Hospitalization | 4 | 1995 | 169 |
Why?
|
Papillomavirus Infections | 2 | 2003 | 39 |
Why?
|
Rural Population | 1 | 1996 | 30 |
Why?
|
Vaginosis, Bacterial | 2 | 2003 | 5 |
Why?
|
HIV | 2 | 2006 | 32 |
Why?
|
Papillomaviridae | 2 | 2003 | 37 |
Why?
|
Urban Population | 1 | 1996 | 80 |
Why?
|
Corynebacterium Infections | 1 | 1994 | 10 |
Why?
|
Aortic Valve | 1 | 1994 | 19 |
Why?
|
Endocarditis, Bacterial | 1 | 1994 | 26 |
Why?
|
Emigration and Immigration | 1 | 1994 | 19 |
Why?
|
Postpartum Period | 3 | 2008 | 32 |
Why?
|
Urban Health | 1 | 1994 | 47 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2002 | 145 |
Why?
|
Cohort Studies | 8 | 1994 | 332 |
Why?
|
Vagina | 2 | 2008 | 30 |
Why?
|
Whooping Cough | 1 | 1993 | 14 |
Why?
|
Treatment Outcome | 4 | 2002 | 661 |
Why?
|
Prospective Studies | 8 | 1993 | 545 |
Why?
|
North Carolina | 4 | 1993 | 12 |
Why?
|
Adolescent Health Services | 1 | 1993 | 23 |
Why?
|
Oximes | 1 | 2010 | 2 |
Why?
|
Transdermal Patch | 1 | 2010 | 3 |
Why?
|
Alcohol-Related Disorders | 1 | 2011 | 17 |
Why?
|
Lopinavir | 1 | 2010 | 11 |
Why?
|
Virus Shedding | 1 | 2010 | 8 |
Why?
|
Nelfinavir | 2 | 2006 | 3 |
Why?
|
Nevirapine | 2 | 2006 | 9 |
Why?
|
Disease Progression | 2 | 2000 | 244 |
Why?
|
Cross-Sectional Studies | 2 | 2002 | 253 |
Why?
|
Cervix Uteri | 1 | 2010 | 38 |
Why?
|
Benzoxazines | 2 | 2006 | 14 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 144 |
Why?
|
Pregnancy Rate | 1 | 2009 | 10 |
Why?
|
Sexual Behavior | 2 | 1996 | 37 |
Why?
|
Physician's Practice Patterns | 2 | 2002 | 149 |
Why?
|
Reverse Transcriptase Inhibitors | 2 | 2005 | 19 |
Why?
|
Drug Administration Schedule | 2 | 2006 | 191 |
Why?
|
Prognosis | 2 | 1994 | 388 |
Why?
|
Infant, Newborn | 5 | 1996 | 389 |
Why?
|
HIV Seronegativity | 1 | 2008 | 13 |
Why?
|
Antiviral Agents | 2 | 1996 | 91 |
Why?
|
Drug Therapy, Combination | 4 | 1994 | 189 |
Why?
|
Interleukin-1beta | 1 | 2008 | 36 |
Why?
|
Health Services Research | 2 | 1997 | 63 |
Why?
|
DNA, Mitochondrial | 1 | 2008 | 32 |
Why?
|
Hemarthrosis | 1 | 2007 | 3 |
Why?
|
Fetal Blood | 1 | 2008 | 54 |
Why?
|
Helicobacter pylori | 1 | 2007 | 10 |
Why?
|
Interleukin-8 | 1 | 2008 | 54 |
Why?
|
Mitochondrial Proteins | 1 | 2008 | 26 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 67 |
Why?
|
Protease Inhibitors | 1 | 2007 | 39 |
Why?
|
Sterilization, Tubal | 1 | 2007 | 7 |
Why?
|
Hemophilia A | 1 | 2007 | 23 |
Why?
|
Cholesterol, LDL | 1 | 2008 | 23 |
Why?
|
Contraception Behavior | 1 | 2007 | 8 |
Why?
|
Chromatography, Liquid | 1 | 2006 | 33 |
Why?
|
Injections | 1 | 2006 | 53 |
Why?
|
Oxazines | 1 | 2006 | 16 |
Why?
|
Area Under Curve | 1 | 2006 | 47 |
Why?
|
Fertility | 1 | 2007 | 32 |
Why?
|
Half-Life | 1 | 2006 | 69 |
Why?
|
Time Factors | 4 | 2003 | 896 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 54 |
Why?
|
Risk-Taking | 1 | 2008 | 36 |
Why?
|
Progesterone | 1 | 2006 | 42 |
Why?
|
Hospitals, Urban | 2 | 1995 | 10 |
Why?
|
Anti-Bacterial Agents | 3 | 1994 | 195 |
Why?
|
AIDS Vaccines | 1 | 2006 | 18 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 78 |
Why?
|
Regression Analysis | 4 | 1994 | 256 |
Why?
|
Viral Vaccines | 1 | 2006 | 35 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 321 |
Why?
|
Interleukin-6 | 1 | 2008 | 145 |
Why?
|
Quality Assurance, Health Care | 3 | 1994 | 83 |
Why?
|
Odds Ratio | 3 | 1996 | 157 |
Why?
|
Hispanic Americans | 2 | 1995 | 57 |
Why?
|
Clinical Protocols | 1 | 2005 | 93 |
Why?
|
Sex Factors | 2 | 1997 | 284 |
Why?
|
Azithromycin | 2 | 2000 | 13 |
Why?
|
Multivariate Analysis | 4 | 1995 | 225 |
Why?
|
Cognition Disorders | 1 | 2007 | 107 |
Why?
|
Virus Replication | 1 | 2006 | 90 |
Why?
|
Uterine Cervicitis | 1 | 2003 | 2 |
Why?
|
Trichomonas Vaginitis | 1 | 2003 | 3 |
Why?
|
Pelvic Inflammatory Disease | 1 | 2003 | 9 |
Why?
|
Lupus Nephritis | 1 | 2003 | 4 |
Why?
|
Retroviridae Infections | 1 | 2003 | 7 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2003 | 7 |
Why?
|
Quality of Life | 2 | 2001 | 188 |
Why?
|
AIDS Serodiagnosis | 1 | 2003 | 10 |
Why?
|
African Americans | 2 | 1995 | 108 |
Why?
|
Zidovudine | 2 | 1989 | 23 |
Why?
|
Specialization | 1 | 2003 | 31 |
Why?
|
Medical History Taking | 1 | 2003 | 53 |
Why?
|
Sex Distribution | 1 | 2003 | 101 |
Why?
|
Primary Prevention | 1 | 2003 | 44 |
Why?
|
Logistic Models | 5 | 1995 | 251 |
Why?
|
Prevalence | 3 | 1993 | 281 |
Why?
|
Clinical Competence | 2 | 2002 | 130 |
Why?
|
Mycobacterium avium | 1 | 2001 | 2 |
Why?
|
Mycobacterium Infections | 1 | 2001 | 11 |
Why?
|
Self-Assessment | 1 | 2001 | 35 |
Why?
|
Severity of Illness Index | 3 | 1994 | 358 |
Why?
|
Antigens | 1 | 2001 | 66 |
Why?
|
Patient Education as Topic | 1 | 2003 | 128 |
Why?
|
Education, Medical | 1 | 2003 | 79 |
Why?
|
Education, Medical, Continuing | 1 | 2002 | 54 |
Why?
|
Quality of Health Care | 3 | 1995 | 85 |
Why?
|
Pneumocystis | 1 | 2001 | 13 |
Why?
|
Fluconazole | 1 | 2000 | 8 |
Why?
|
Candidiasis, Oral | 1 | 2000 | 12 |
Why?
|
Estrogen Replacement Therapy | 1 | 2000 | 21 |
Why?
|
Vaginal Douching | 2 | 2008 | 2 |
Why?
|
Menopause | 1 | 2000 | 27 |
Why?
|
Antifungal Agents | 1 | 2000 | 34 |
Why?
|
Health Services | 1 | 1999 | 44 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2002 | 113 |
Why?
|
Health Care Costs | 1 | 1999 | 73 |
Why?
|
Substance Abuse, Intravenous | 2 | 1994 | 15 |
Why?
|
Research Design | 1 | 1999 | 169 |
Why?
|
Triglycerides | 2 | 2007 | 48 |
Why?
|
Health Care Coalitions | 1 | 1997 | 3 |
Why?
|
Double-Blind Method | 3 | 2000 | 274 |
Why?
|
Cholesterol, HDL | 2 | 2007 | 26 |
Why?
|
Ulcer | 1 | 1996 | 19 |
Why?
|
Vaginal Diseases | 1 | 1996 | 16 |
Why?
|
Vulvar Diseases | 1 | 1996 | 19 |
Why?
|
Confidence Intervals | 2 | 1993 | 104 |
Why?
|
Health Resources | 1 | 1996 | 19 |
Why?
|
Tuberculosis | 1 | 1997 | 24 |
Why?
|
Insurance, Hospitalization | 1 | 1995 | 3 |
Why?
|
Disease Outbreaks | 1 | 1997 | 61 |
Why?
|
Chicago | 4 | 1994 | 4 |
Why?
|
Los Angeles | 4 | 1994 | 8 |
Why?
|
Florida | 4 | 1994 | 15 |
Why?
|
Minority Groups | 1 | 1995 | 38 |
Why?
|
Postmenopause | 2 | 2000 | 27 |
Why?
|
Length of Stay | 1 | 1996 | 166 |
Why?
|
Corynebacterium | 1 | 1994 | 6 |
Why?
|
Patient Care Planning | 1 | 1995 | 55 |
Why?
|
Heart Valve Diseases | 1 | 1994 | 18 |
Why?
|
Heart Valve Prosthesis | 1 | 1994 | 23 |
Why?
|
Bacteremia | 1 | 1994 | 25 |
Why?
|
Education | 1 | 1994 | 28 |
Why?
|
Patient Admission | 1 | 1994 | 72 |
Why?
|
Microbial Sensitivity Tests | 1 | 1994 | 71 |
Why?
|
Employment | 1 | 1994 | 47 |
Why?
|
Follow-Up Studies | 2 | 1993 | 553 |
Why?
|
Life Style | 1 | 1994 | 55 |
Why?
|
Community Health Services | 1 | 1994 | 60 |
Why?
|
Forecasting | 1 | 1994 | 147 |
Why?
|
Health Education | 1 | 1994 | 57 |
Why?
|
Health Services Needs and Demand | 1 | 1994 | 66 |
Why?
|
Health Behavior | 1 | 1994 | 61 |
Why?
|
Bordetella pertussis | 1 | 1993 | 9 |
Why?
|
Nasopharynx | 1 | 1993 | 27 |
Why?
|
Placebos | 2 | 2000 | 110 |
Why?
|
Multicenter Studies as Topic | 2 | 1996 | 70 |
Why?
|
Family | 1 | 1994 | 101 |
Why?
|
Social Support | 1 | 1994 | 111 |
Why?
|
Bronchoscopy | 3 | 1995 | 27 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1993 | 68 |
Why?
|
Fungi | 1 | 2010 | 15 |
Why?
|
Referral and Consultation | 2 | 2002 | 134 |
Why?
|
Kenya | 1 | 2010 | 4 |
Why?
|
Washington | 1 | 2010 | 12 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2010 | 8 |
Why?
|
Cervical Intraepithelial Neoplasia | 1 | 2010 | 16 |
Why?
|
Vaginal Smears | 1 | 2010 | 31 |
Why?
|
Bacteria | 1 | 2010 | 42 |
Why?
|
Gravidity | 1 | 2009 | 6 |
Why?
|
Premenopause | 1 | 2009 | 16 |
Why?
|
Sex Education | 1 | 2009 | 10 |
Why?
|
Retrospective Studies | 4 | 1995 | 653 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 55 |
Why?
|
Congenital Abnormalities | 1 | 2009 | 25 |
Why?
|
Longitudinal Studies | 2 | 1997 | 195 |
Why?
|
Thallium Radioisotopes | 1 | 1988 | 12 |
Why?
|
Sarcoma, Kaposi | 1 | 1988 | 15 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2009 | 27 |
Why?
|
Aged | 4 | 1997 | 988 |
Why?
|
Tablets | 1 | 2008 | 8 |
Why?
|
Genotype | 1 | 2010 | 175 |
Why?
|
DNA, Viral | 1 | 2010 | 98 |
Why?
|
Vaginal Discharge | 1 | 2008 | 2 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 1 | 2008 | 2 |
Why?
|
Body Height | 1 | 2008 | 36 |
Why?
|
Apolipoprotein A-I | 1 | 2008 | 19 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 43 |
Why?
|
Lipoprotein(a) | 1 | 2008 | 12 |
Why?
|
Birth Weight | 1 | 2008 | 50 |
Why?
|
Practice (Psychology) | 1 | 2007 | 7 |
Why?
|
Safety | 1 | 2007 | 80 |
Why?
|
Contraceptive Devices | 1 | 2007 | 2 |
Why?
|
Infant, Low Birth Weight | 1 | 2007 | 31 |
Why?
|
Reproducibility of Results | 2 | 1999 | 391 |
Why?
|
Cytochromes c | 1 | 2008 | 29 |
Why?
|
Lactic Acid | 1 | 2007 | 44 |
Why?
|
Decision Making | 1 | 2009 | 130 |
Why?
|
Pregnancy Outcome | 1 | 2007 | 54 |
Why?
|
Inflammation | 1 | 2010 | 208 |
Why?
|
Cytokines | 1 | 2010 | 207 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 224 |
Why?
|
Apolipoproteins B | 1 | 2008 | 18 |
Why?
|
Skin Neoplasms | 1 | 1988 | 97 |
Why?
|
Continental Population Groups | 1 | 2006 | 85 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 113 |
Why?
|
Blotting, Western | 1 | 2008 | 275 |
Why?
|
Stavudine | 1 | 2005 | 3 |
Why?
|
T-Lymphocytes | 1 | 1989 | 182 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 279 |
Why?
|
Lamivudine | 1 | 2005 | 18 |
Why?
|
Case-Control Studies | 1 | 2007 | 283 |
Why?
|
Hepatitis A Antibodies | 1 | 2003 | 2 |
Why?
|
Hepatitis A Vaccines | 1 | 2003 | 3 |
Why?
|
Mumps virus | 1 | 2003 | 7 |
Why?
|
Hospital Mortality | 2 | 1994 | 60 |
Why?
|
Recurrence | 1 | 2006 | 261 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 27 |
Why?
|
Medicine | 1 | 2003 | 26 |
Why?
|
Antibodies, Bacterial | 1 | 2003 | 50 |
Why?
|
Infant | 1 | 2008 | 464 |
Why?
|
Biopsy | 1 | 2003 | 207 |
Why?
|
Urban Health Services | 1 | 2002 | 14 |
Why?
|
Skin Tests | 1 | 2001 | 28 |
Why?
|
Antigens, Bacterial | 1 | 2001 | 44 |
Why?
|
Biological Markers | 1 | 2003 | 262 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 179 |
Why?
|
Esophagitis | 1 | 2000 | 11 |
Why?
|
Lymphocytes | 1 | 2001 | 142 |
Why?
|
Candida | 1 | 2000 | 19 |
Why?
|
Immunocompromised Host | 1 | 2000 | 70 |
Why?
|
Sample Size | 1 | 1999 | 24 |
Why?
|
Aged, 80 and over | 1 | 2007 | 599 |
Why?
|
Treatment Failure | 1 | 2000 | 88 |
Why?
|
Patient Satisfaction | 1 | 2002 | 120 |
Why?
|
Random Allocation | 1 | 1999 | 160 |
Why?
|
Proportional Hazards Models | 1 | 2000 | 123 |
Why?
|
Cell Division | 1 | 2001 | 273 |
Why?
|
Data Collection | 1 | 1999 | 137 |
Why?
|
Probability | 1 | 1999 | 190 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 427 |
Why?
|
Primary Health Care | 1 | 2003 | 151 |
Why?
|
Patient Selection | 1 | 1999 | 155 |
Why?
|
Models, Statistical | 1 | 1999 | 114 |
Why?
|
Incidence | 1 | 2000 | 336 |
Why?
|
Oral Ulcer | 1 | 1996 | 3 |
Why?
|
Hospitals, Veterans | 1 | 1996 | 15 |
Why?
|
Resuscitation Orders | 1 | 1996 | 14 |
Why?
|
Medicaid | 1 | 1996 | 48 |
Why?
|
Health Surveys | 1 | 1996 | 103 |
Why?
|
Homosexuality, Male | 1 | 1995 | 13 |
Why?
|
New York City | 1 | 1995 | 32 |
Why?
|
Critical Illness | 1 | 1995 | 34 |
Why?
|
Intensive Care Units | 1 | 1996 | 53 |
Why?
|
Outcome and Process Assessment (Health Care) | 1 | 1995 | 63 |
Why?
|
Veterans | 1 | 1995 | 16 |
Why?
|
Medical Records | 1 | 1995 | 104 |
Why?
|
Insurance, Health | 1 | 1996 | 58 |
Why?
|
Cluster Analysis | 1 | 1994 | 66 |
Why?
|
Attitude of Health Personnel | 1 | 1997 | 165 |
Why?
|
European Continental Ancestry Group | 1 | 1995 | 117 |
Why?
|
Survival Rate | 1 | 1995 | 250 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 402 |
Why?
|
Colony-Forming Units Assay | 1 | 1989 | 27 |
Why?
|
Leukocyte Count | 1 | 1989 | 94 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1988 | 20 |
Why?
|
Lymph Nodes | 1 | 1988 | 106 |
Why?
|
Lung Neoplasms | 1 | 1988 | 159 |
Why?
|
